Molecular Templates, Inc. filed SEC Form 8-K: Termination Of A Material Definitive Agreement On April 1, 2021, Molecular Templates, Inc, Other Events On April 5, 2021, The Company Issued A Press Release Announcing Its Decision To Discontinue The Development Of Mt-3724 And Focus Its Resources On The Development Of Next-Generation Engineered Toxin Bodies, Including Tak-169, Which The Company Will Assume Full Rights Of Pursuant To The Termination Described Above